Cetera Investment Advisers
AXSM icon

Cetera Investment Advisers’s Axsome Therapeutics AXSM Stock Holding History

Cetera Investment Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
10,719
+1,013
+10% +$175K ﹤0.01% 2370
2025
Q4 		$1.77M Buy
9,706
+38
+0.4% +$5.3K ﹤0.01% 2322
2025
Q3 		$1.17M Buy
9,668
+2,448
+34% +$276K ﹤0.01% 2642
2025
Q2 		$754K Buy
7,220
+65
+0.9% +$6.88K ﹤0.01% 2636
2025
Q1 		$834K Buy
7,155
+46
+0.6% +$5.24K ﹤0.01% 2410
2024
Q4 		$601K Buy
7,109
+1,160
+19% +$107K ﹤0.01% 2539
2024
Q3 		$535K Sell
5,949
-183
-3% -$16K ﹤0.01% 2602
2024
Q2 		$494K Buy
6,132
+457
+8% +$33.8K ﹤0.01% 2607
2024
Q1 		$453K Buy
+5,675
New +$476K ﹤0.01% 2675

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Investment Advisers's AXSM Position: Q1 2026 in Review

Cetera Investment Advisers increased its Axsome Therapeutics (AXSM) stake by 10% in Q1 2026, buying an estimated $175K and bringing the position to 10,719 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Cetera Investment Advisers first reported a position in AXSM in Q1 2024 and has held it in 9 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Cetera Investment Advisers held 10,719 shares of Axsome Therapeutics worth $1.81M as of Q1 2026.
  • Cetera Investment Advisers bought 1,013 Axsome Therapeutics shares in Q1 2026, an estimated $175K.
  • Axsome Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2370 holding.
  • Cetera Investment Advisers first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.